3rd TRT Bellwether Trial to Begin on November 6, 2017
3rd TRT Bellwether Trial to Begin on November 6, 2017
Introduction
The third Testosterone Replacement Therapy bellwether lawsuit is scheduled to go before the jury on November 6 with Auxilium Pharmaceuticals as the defendant for their testosterone based Testim gel. The second Auxilium trial is set for April 9, 2018. Thousands of men have filed lawsuits against Testim gel maker, claiming failure to adequately warn about the potentially life-threatening injuries like heart attacks, stroke, pulmonary embolism, deep vein thrombosis and other blood clots, and death. The company had promoted Testim gel aggressively for the treatment of "Low T" symptoms. The gel works as a reservoir of testosterone that sticks to the skin and delivers the drug through the skin.
Latest News
Teen E-cigarette Use Hits 10-Year Low
Federal officials report a significant decline in teen vaping rates in the U.S., with about half a million fewer middle and high school…
Baltimore, Walgreens Reach Opioid Settlement Totaling $402.5m
The City of Baltimore has reached a settlement with Walgreens over its involvement in the opioid crisis, marking the…